RxSight Inc. (RXST)
undefined
undefined%
At close: undefined
37.30
0.24%
After-hours Dec 13, 2024, 04:00 PM EST

Company Description

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally.

It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.

The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery.

It primarily serves cataract doctors.

The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017.

RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

RxSight Inc.
RxSight Inc. logo
Country United States
IPO Date Jul 30, 2021
Industry Medical - Devices
Sector Healthcare
Employees 374
CEO Dr. Ronald M. Kurtz M.D.

Contact Details

Address:
100 Columbia
Aliso Viejo, California
United States
Website https://www.rxsight.com

Stock Details

Ticker Symbol RXST
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001111485
CUSIP Number 78349D107
ISIN Number US78349D1072
Employer ID 94-3268801
SIC Code 3851

Key Executives

Name Position
Dr. Ronald M. Kurtz M.D. President, Chief Executive Officer & Director
Dr. Ilya Goldshleger Ph.D. Co-President & Chief Operating Officer
Matt Haller Ph.D. Chief Technology Officer
Shelley B. Thunen Co-President & Chief Financial Officer
Caroline Vaughn Vice President of Human Resources
Eric J. Weinberg Co-President & Chief Commercial Officer
Oliver Moravcevic Vice President of Investor Relations
Rebecca Williston Vice President of Accounting & Finance
Roy Freeman Senior Vice President of Marketing & Professional Relations
Steve Everly Senior Vice President of Sales of North America

Latest SEC Filings

Date Type Title
Dec 03, 2024 4 Filing
Nov 26, 2024 4 Filing
Nov 26, 2024 4 Filing
Nov 18, 2024 4 Filing
Nov 14, 2024 4 Filing
Nov 14, 2024 4 Filing
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 08, 2024 4 Filing